J.P. Morgan Stockwatch: No Substitute For M&A
Clinical, Regulatory, Commercial News Fails To Ignite Shares
Executive Summary
Stock market reaction to the first day’s news from the 38th J.P. Morgan Healthcare conference in San Francisco was negative, probably because expectations for a continuation of December’s bumper M&A bonanza were too high.